Urologic Consultants of Southeastern Pennsylvania

Urologic Consultants of Southeastern Pennsylvania is a premier medical group providing comprehensive urological care and advanced clinical research services in the Philadelphia region. The practice specializes in the diagnosis and treatment of urologic malignancies, including prostate, bladder, and kidney cancers, as well as general urological conditions such as BPH and kidney stones. A key differentiator for the group is its robust clinical research department, which participates in numerous Phase 1 through Phase 3 multi-center clinical trials for novel therapeutics and medical devices. In 2018, the practice merged with other regional groups to form MidLantic Urology, which subsequently became a founding member of the Solaris Health platform. The organization remains a leader in robotic-assisted surgery and minimally invasive urological interventions.